While intensive chemotherapy and allogeneic hematopoietic stem cell (HSC) transplantation remain the front-line treatment option for most persons, recent US Food and Drug Administration (FDA)-approved targeted therapeutics are increasingly used to treat persons with specific genetic aberrations, such as IDH1 or FLT3 internal tandem duplication (ITD) mutations
The findings are useful for the protection of food and beverages against undesired effects of light exposure, i.e., for preventing premature quality loss and for the co-encapsulation of folic acid with those antioxidants as an effective way to protect the vitamin B 9 551,552,553
Participants and methods Subjects The protocol for the entire investigation was approved by the Human Research Ethic Committee of Thammasat University (COA 097/2556)
doi: 10.1007/s00394-020-02473-0 12
10.1016/j.tox.2014.01.010 44 PizzurroD
Water retention affects many individuals managing weight and metabolic health